Comparative Outcomes: Talquetamab vs Physician's Choice in R/R Multiple Myeloma

Opinion
Video

Panelists discuss how talquetamab demonstrates superior efficacy compared with physician-chosen treatments for patients with heavily pretreated multiple myeloma, with improved progression-free survival and response rates.

Recent Videos
4 experts in this video
4 experts in this video
2 experts in this video
Related Content